EcoDrugPlus

Ribosomal Protein S7

Ensembl ID : ENSIPUG00000023071
Gene Symbol: RPS7
3 Cross references
57 Possible Orthologues:

Ribosomal Protein S8a

Ensembl ID : ENSIPUG00000007345
Gene Symbol: RPS8A
3 Cross references
326 Possible Orthologues:

Ribosomal Protein S9

Ensembl ID : ENSIPUG00000000061
Gene Symbol: RPS9
3 Cross references
235 Possible Orthologues:

Ribosomal Protein Sa

Ensembl ID : ENSIPUG00000003859
Gene Symbol: RPSA
2 Cross references
516 Possible Orthologues:

Ribosomal Protein, Large, P0

Ensembl ID : ENSIPUG00000011275
Gene Symbol: RPLP0
2 Cross references
398 Possible Orthologues:

Ribosomal Protein, Large, P1

Ensembl ID : ENSIPUG00000003514
Gene Symbol: RPLP1
3 Cross references
382 Possible Orthologues:

Selectin P

Ensembl ID : ENSIPUG00000023961
Gene Symbol: SELP
4 Cross references
123 Possible Orthologues:

Serine/threonine-Protein Kinase D3

Ensembl ID : ENSIPUG00000006387
Gene Symbol: LOC108258044
3 Cross references
201 Possible Orthologues:

Serine/threonine-Protein Kinase Pak 6

Ensembl ID : ENSIPUG00000019963
Gene Symbol: LOC108269614
3 Cross references
166 Possible Orthologues:

Serine/threonine-Protein Kinase Pim-2-Like

Ensembl ID : ENSIPUG00000006266
Gene Symbol: LOC108261215
2 Cross references
112 Possible Orthologues:

Serine/threonine-Protein Kinase Pim-2-Like

Ensembl ID : ENSIPUG00000008517
Gene Symbol: LOC108261509
2 Cross references
112 Possible Orthologues:

Serine/threonine-Protein Kinase Pim-3

Ensembl ID : ENSIPUG00000010614
Gene Symbol: LOC108280133
3 Cross references
172 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).